BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 10541269)

  • 1. Role of urinary bikunin in the inhibition of calcium oxalate crystallization.
    Atmani F; Khan SR
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S385-8. PubMed ID: 10541269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of inter-alpha-inhibitor and several of its derivatives on calcium oxalate crystallization in vitro.
    Dean C; Kanellos J; Pham H; Gomes M; Oates A; Grover P; Ryall R
    Clin Sci (Lond); 2000 Apr; 98(4):471-80. PubMed ID: 10731483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bikunin prevents adhesion of calcium oxalate crystal to renal tubular cells in human urine.
    Ebisuno S; Nishihata M; Inagaki T; Umehara M; Kohjimoto Y
    J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S436-40. PubMed ID: 10541279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effect of bikunin on calcium oxalate crystallization in vitro and urinary bikunin decrease in renal stone formers.
    Médétognon-Benissan J; Tardivel S; Hennequin C; Daudon M; Drüeke T; Lacour B
    Urol Res; 1999; 27(1):69-75. PubMed ID: 10092156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nephrolithiasis: a consequence of renal epithelial cell exposure to oxalate and calcium oxalate crystals.
    Khan SR; Thamilselvan S
    Mol Urol; 2000; 4(4):305-12. PubMed ID: 11156696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inter-alpha-inhibitor: a protein family involved in the inhibition of calcium oxalate crystallization.
    Atmani F; Mizon J; Khan SR
    Scanning Microsc; 1996; 10(2):425-33; discussion 433-4. PubMed ID: 9813621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of structural domains in inter-alpha-trypsin involved in calcium oxalate crystallization.
    Kobayashi H; Shibata K; Fujie M; Sugino D; Terao T
    Kidney Int; 1998 Jun; 53(6):1727-35. PubMed ID: 9607205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole urinary proteins coat calcium oxalate monohydrate crystals to greatly decrease their adhesion to renal cells.
    Kumar V; Farell G; Lieske JC
    J Urol; 2003 Jul; 170(1):221-5. PubMed ID: 12796693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alpha-1-microglobulin: inhibitory effect on calcium oxalate crystallization in vitro and decreased urinary concentration in calcium oxalate stone formers.
    Tardivel S; Médétognon J; Randoux C; Kébédé M; Drüeke T; Daudon M; Hennequin C; Lacour B
    Urol Res; 1999 Aug; 27(4):243-9. PubMed ID: 10460893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of inter-alpha inhibitor related proteins in kidneys and urine of hyperoxaluric rats.
    Moriyama MT; Glenton PA; Khan SR
    J Urol; 2001 May; 165(5):1687-92. PubMed ID: 11342956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of various modifiers on calcium oxalate crystallization.
    Kulaksizoglu S; Sofikerim M; Cevik C
    Int J Urol; 2007 Mar; 14(3):214-8. PubMed ID: 17430258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Uronic-acid-rich protein: a new glycoprotein inhibiting the crystallization of calcium oxalate in vitro].
    Atmani F; Lacour B; Daudon M
    Nephrologie; 1996; 17(3):157-62. PubMed ID: 9064564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystalline aggregation in vitro: interaction between urinary macromolecules and the micromolecular environment.
    Guerra A; Meschi T; Schianchi T; Allegri F; Novarini A; Borghi L
    Acta Biomed; 2002; 73(1-2):11-26. PubMed ID: 12233273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors determining types and morphologies of calcium oxalate crystals: molar concentrations, buffering, pH, stirring and temperature.
    Thongboonkerd V; Semangoen T; Chutipongtanate S
    Clin Chim Acta; 2006 May; 367(1-2):120-31. PubMed ID: 16458875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of Tamm-Horsfall glycoprotein and Nephrocalcin in calcium oxalate monohydrate crystallization processes.
    Hess B
    Scanning Microsc; 1991 Sep; 5(3):689-95; discussion 696. PubMed ID: 1808706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excretion of bikunin and its fragments in the urine of patients with renal stones.
    Suzuki M; Kobayashi H; Kageyama S; Shibata K; Fujie M; Terao T
    J Urol; 2001 Jul; 166(1):268-74. PubMed ID: 11435884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of urinary inter-alpha-trypsin inhibitor trimers and dimers in normal compared to active calcium oxalate stone forming men.
    Marengo SR; Resnick MI; Yang L; Chung JY
    J Urol; 1998 May; 159(5):1444-50. PubMed ID: 9554330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary glycosaminoglycans and glycoproteins in a calcium oxalate crystallization system.
    Poon NW; Gohel MD
    Carbohydr Res; 2012 Jan; 347(1):64-8. PubMed ID: 22119438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Temporal changes in mRNA expression for bikunin in the kidneys of rats during calcium oxalate nephrolithiasis.
    Iida S; Peck AB; Johnson-Tardieu J; Moriyama M; Glenton PA; Byer KJ; Khan SR
    J Am Soc Nephrol; 1999 May; 10(5):986-96. PubMed ID: 10232684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
    Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.